KATHERINE ZWIEBEL: Open Payments
NPI 1689102881 · SAINT MARYS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,581 in 99 payments from 23 companies in 2025. Trend: 2023 $1,670 · 2024 $1,895 · 2025 $1,581
Food & beverage: $1,581
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $628 |
| EMD Serono, Inc. | 6 | $114 |
| Neurocrine BioSciences, Inc. | 6 | $110 |
| Alexion Pharmaceuticals, Inc. | 3 | $76 |
| Biogen, Inc. | 4 | $75 |
| SK Life Science, Inc. | 4 | $65 |
| Eisai Inc. | 3 | $58 |
| Lilly USA, LLC | 3 | $50 |
| Lundbeck LLC | 3 | $50 |
| PFIZER INC. | 3 | $48 |
Products named: QULIPTA, UBRELVY, INGREZZA, BOTOX, ULTOMIRIS, Leqembi, TYSABRI, AMYVID.
Industry payments across OH — which companies pay providers there.
